Traditional Chinese medicine Astragalus polysaccharide enhanced antitumor effects of the angiogenesis inhibitor apatinib in pancreatic cancer cells on proliferation, invasiveness, and apoptosis

References

• SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
   PubMed Web of Science ®Google Scholar
• ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
   PubMed Web of Science ®Google Scholar
• KoobyDAGillespieTWLiuYImpact of adjuvant radiotherapy on survival after pancreatic cancer resection: an appraisal of data from the national cancer data baseAnn Surg Oncol201320113634364223771249
   PubMed Web of Science ®Google Scholar
• HicklinDJEllisLMRole of the vascular endothelial growth factor pathway in tumor growth and angiogenesisJ Clin Oncol20052351011102715585754
   PubMed Web of Science ®Google Scholar
• BüchlerPReberHABüchlerMWFriessHHinesOJVEGF-RII influences the prognosis of pancreatic cancerAnn Surg2002236673874912454512
   PubMed Web of Science ®Google Scholar
• LuoJGuoPMatsudaKPancreatic cancer cell-derived vascular endothelial growth factor is biologically active in vitro and enhances tumorigenicity in vivoInt J Cancer200192336136911291072
   PubMed Web of Science ®Google Scholar
• TianSQuanHXieCYN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase with potent activity in vitro and in vivoCancer Sci201110271374138021443688
   PubMed Web of Science ®Google Scholar
• LiJQinSXuJRandomized, double-blind, placebo-controlled phase III trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junctionJ Clin Oncol201634131448145426884585
   PubMed Web of Science ®Google Scholar
• ZhangHApatinib for molecular targeted therapy in tumorDrug Des Devel Ther2015960756081
   PubMed Web of Science ®Google Scholar
• PengHZhangQLiJApatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinomaOncotarget2016713172201722926967384
   PubMedGoogle Scholar
• PengSZhangYPengHIntracellular autocrine VEGF signaling promotes EBDC cell proliferation, which can be inhibited by apatinibCancer Lett2016373219320226805764
   PubMed Web of Science ®Google Scholar
• XuJLiuXYangSZhangXShiYApatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective studyOnco Targets Ther2017104989499529075129
   PubMed Web of Science ®Google Scholar
• LuoCShenJYingJCase report of a KIT-mutated melanoma patient with an excellent response to apatinib and temozolomide combination therapyOnco Targets Ther2017104553455729066909
   PubMed Web of Science ®Google Scholar
• HuangWHLiaoWRSunRXAstragalus polysaccharide induces the apoptosis of Human hepatocellular carcinoma cells by decreasing the expression of Notch1Int J Mol Med201638255155727279598
   PubMed Web of Science ®Google Scholar
• LiJBaoYLamWImmunoregulatory and anti-tumor effects of polysaccharopeptide and Astragalus polysaccharides on tumor-bearing miceImmunopharmacol Immunotoxicol200830477178218686097
   PubMed Web of Science ®Google Scholar
• GuoLBaiSPZhaoLWangXHAstragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer: effects on quality of life and survivalMed Oncol20122931656166221928106
   PubMed Web of Science ®Google Scholar
• TianQEDe LiHYanMCaiHLTanQYZhangWYEffects of Astragalus polysaccharides on P-glycoprotein efflux pump function and protein expression in H22 hepatoma cells in vitroBMC Complement Altern Med2012129422784390
   PubMed Web of Science ®Google Scholar
• ChiaravalliMReniMO’ReillyEMPancreatic ductal adenocarcinoma: state-of-the-art 2017 and new therapeutic strategiesCancer Treat Rev201760324328869888
   PubMed Web of Science ®Google Scholar
• SaridakiZAndroulakisNVardakisNA triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trialBr J Cancer2012107121932193723169296
   PubMed Web of Science ®Google Scholar
• OttaianoACapozziMDe DivitiisCGemcitabine mono-therapy versus gemcitabine plus targeted therapy in advanced pancreatic cancer: a meta-analysis of randomized phase III trialsActa Oncol201756337738328256961
   PubMed Web of Science ®Google Scholar
• KindlerHLNiedzwieckiDHollisDGemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the cancer and leukemia group B (CALGB 80303)J Clin Oncol201028223617362220606091
   PubMed Web of Science ®Google Scholar
• LiCMLiuZCBaoYTSunXDWangLExtraordinary response of metastatic pancreatic cancer to apatinib after failed chemotherapy: a case report and literature reviewWorld J Gastroenterol201723417478748829151702
   PubMed Web of Science ®Google Scholar
• LiangLWangLZhuPApatinib concurrent gemcitabine for controlling malignant ascites in advanced pancreatic cancer patient: a case reportMedicine20179647e872529381963
   PubMed Web of Science ®Google Scholar
• LiQBaoJMLiXLZhangTShenXHInhibiting effect of Astragalus polysaccharides on the functions of CD4+CD25 highTreg cells in the tumor microenvironment of human hepatocellular carcinomaChin Med J (Engl)2012125578679322490576
   PubMed Web of Science ®Google Scholar
• ZhangDZhengJNiMComparative efficacy and safety of Chinese herbal injections combined with the FOLFOX regimen for treating gastric cancer in China: a network meta-analysisOncotarget2017840688736888928978164
   PubMedGoogle Scholar
• WuJYuJWangJAstragalus polysaccharide enhanced antitumor effects of apatinib in gastric cancer AGS cells by inhibiting AKT signalling pathwayBiomed Pharmacother201810017618329428665
   PubMed Web of Science ®Google Scholar
• XuYLiZJiangPThe co-expression of MMP-9 and tenascin-C is significantly associated with the progression and prognosis of pancreatic cancerDiagn Pathol20151021126652622
   PubMed Web of Science ®Google Scholar
• CandidoSAbramsSLSteelmanLSRoles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapyBiochim Biophys Acta20161863343844826278055
   PubMed Web of Science ®Google Scholar
• AsatiVMahapatraDKBhartiSKPI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: structural and pharmacological perspectivesEur J Med Chem201610931434126807863
   PubMed Web of Science ®Google Scholar
• McCubreyJASteelmanLSChappellWHRole of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceBiochim Biophys Acta2007177381263128417126425
   PubMed Web of Science ®Google Scholar
• MannKMYingHJuanJJenkinsNACopelandNGKRAS-related proteins in pancreatic cancerPharmacol Ther2016168294227595930
   PubMed Web of Science ®Google Scholar
• SimonsMGordonEClaesson-WelshLMechanisms and regulation of endothelial VEGF receptor signallingNat Rev Mol Cell Biol2016171061162527461391
   PubMed Web of Science ®Google Scholar
• GalluzziLBravo-San PedroJMDemariaSFormentiSCKroemerGActivating autophagy to potentiate immunogenic chemotherapy and radiation therapyNat Rev Clin Oncol201714424725827845767
   PubMed Web of Science ®Google Scholar
• GómezVEGiovannettiEPetersGJUnraveling the complexity of autophagy: potential therapeutic applications in pancreatic ductal adenocarcinomaSemin Cancer Biol201535111926408419
   PubMed Web of Science ®Google Scholar
• AldertonGKAutophagy: surviving stress in pancreatic cancerNat Rev Cancer201515951326299587
   PubMed Web of Science ®Google Scholar
• DalbyKNTekedereliILopez-BeresteinGOzpolatBTargeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancerAutophagy20106332232920224296
   PubMed Web of Science ®Google Scholar